Key result
Optimizing strategies for the identification of congestive heart failure and distinguishing between HFrEF and HFpEF is imperative in the current era of evidence-based treatments.
Answers are grounded in this paper and cite their sources.
Highlights the imperative need for optimized strategies to identify congestive heart failure and distinguish between HFrEF and HFpEF in the era of evidence-based treatments.
Given the fact that we are now practising medicine in an era where the standard of care is the optimisation of evidence-based treatments -both for heart failure with reduced ejection fraction (HFrEF) and for heart failure with preserved ejection fraction (HFpEF) -it is imperative that strategies should also be optimised both for identification of congestive heart failure (CHF) and for establishing a distinction between HFrEF and HFpEF.
No takes yet. Share an insight, caveat, or question.
Oscar M.P. Jolobe (2024) conducted a letter in Heart failure. Optimizing strategies for the identification of congestive heart failure and distinguishing between HFrEF and HFpEF is imperative in the current era of evidence-based treatments.
Synapse has enriched 10 related papers. Consider them for comparative context: